Evolution of outcomes in autologous stem cell transplantation for hodgkin lymphoma over 2 decades at King Hussein cancer center

Abstract Autologous hematopoietic stem cell transplantation (auto-HCT) remains a cornerstone in relapsed Hodgkin lymphoma (HL), especially where access to novel agents is limited. We evaluated trends in outcomes after auto-HCT at King Hussein Cancer Center (KHCC) over two decades. We retrospectively...

Full description

Bibliographic Details

Published in:	Annals of Hematology
Main Authors:	Zaid Abdel Rahman, Abeer Yaseen, Anas Zayed, Lina Alkhdour, Mona Ribie, Albatol Alamoush, Fareed Barakat, Mohammad Alrawashdeh, Alaa Abu Fara, Khalid Halahleh, Omar Shahin, Akram Al-Ibraheem, Mohammad Ma’koseh
Format:	Article
Language:	English
Published:	Springer 2026-03-01
Subjects:	Hodgkin lymphoma Autologous stem cell transplantation Salvage chemotherapy Immune checkpoint inhibitors Real-world outcomes Low-and middle-income countries (LMIC)
Online Access:	https://doi.org/10.1007/s00277-026-06870-z